🧬
Biyoteknoloji Sektörü Hisseleri
Biyoteknoloji Sektörü altında 522 Hisse Senedi
Biyoteknoloji sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.
Biyoteknoloji Sektörü Hakkında
Biyoteknoloji sektörü, genetik mühendisliği, ilaç geliştirme ve tıbbi araştırma alanında faaliyet gösteren şirketleri kapsar. Yüksek AR-GE yatırımları ve uzun geliştirme süreçleri ile karakterize edilir.
Temel Özellikler
- Yüksek AR-GE yatırımları
- Uzun geliştirme süreçleri
- Düzenleyici onay riskleri
- Yüksek büyüme potansiyeli
Önemli Şirketler
ModernaGilead SciencesBiogenRegeneron
522
Toplam Hisse
$2.5T
Toplam Piyasa Değeri
Biyoteknoloji Sektörü Hisseleri
Sayfa 5/6 (Toplam: 522)
| SEMBOL | ŞİRKET | PİYASA DEĞERİ | FİYAT | DEĞİŞİM | |
|---|---|---|---|---|---|
| ANVS | Annovis Bio, Inc. | $33.13M | $2.35 | 2.08% | |
| BLUE | bluebird bio, Inc. | $32.41M | $4.97 | 0.00% | |
| FBLG | FibroBiologics, Inc. Common Stock | $32.37M | $0.73 | 2.73% | |
| OCUP | Ocuphire Pharma, Inc. | $31.74M | $1.17 | 12.03% | |
| SCLX | Scilex Holding Company | $31.60M | $5.12 | 9.38% | |
| KZR | Kezar Life Sciences, Inc. | $31.12M | $4.18 | 0.24% | |
| FGEN | FibroGen, Inc. | $30.82M | $0.29 | 9.59% | |
| MRNS | Marinus Pharmaceuticals, Inc. | $30.37M | $0.55 | 0.00% | |
| ALLK | Allakos Inc. | $29.76M | $0.33 | 0.22% | |
| FEMY | Femasys Inc. | $29.56M | $0.88 | 13.73% | |
| CASI | CASI Pharmaceuticals, Inc. | $28.82M | $1.89 | 0.53% | |
| RANI | Rani Therapeutics Holdings, Inc. | $28.78M | $0.56 | 3.45% | |
| CVKD | Cadrenal Therapeutics, Inc. Common Stock | $28.40M | $13.33 | 0.26% | |
| INKT | MiNK Therapeutics, Inc. | $27.81M | $7.03 | 1.01% | |
| GBIO | Generation Bio Co. | $26.20M | $0.38 | 2.58% | |
| ALXO | ALX Oncology Holdings Inc. | $25.71M | $0.49 | 3.92% | |
| BCAB | BioAtla, Inc. | $25.68M | $0.41 | 4.60% | |
| EGRX | Eagle Pharmaceuticals, Inc. | $25.53M | $1.80 | 9.09% | |
| DARE | Daré Bioscience, Inc. | $25.49M | $2.97 | 3.13% | |
| TPST | Tempest Therapeutics, Inc. | $23.76M | $5.95 | 2.94% | |
| CRIS | Curis, Inc. | $23.02M | $2.46 | 9.33% | |
| IPA | ImmunoPrecise Antibodies Ltd. | $22.88M | $0.57 | 0.73% | |
| PULM | Pulmatrix, Inc. | $22.72M | $8.98 | 9.51% | |
| KALA | Kala Pharmaceuticals, Inc. | $22.49M | $3.72 | 3.13% | |
| CVM | CEL-SCI Corporation | $21.52M | $2.10 | 11.02% | |
| OVID | Ovid Therapeutics Inc. | $21.06M | $0.27 | 9.54% | |
| QTTB | Q32 Bio Inc. | $20.59M | $1.73 | 8.47% | |
| LGVN | Longeveron Inc. | $20.56M | $1.24 | 5.34% | |
| ELEV | Elevation Oncology, Inc. | $20.45M | $0.30 | 1.96% | |
| NNVC | NanoViricides, Inc. | $19.78M | $1.52 | 3.18% | |
| PIRS | Pieris Pharmaceuticals, Inc. | $17.96M | $13.60 | 15.58% | |
| HOOK | HOOKIPA Pharma Inc. | $17.61M | $1.59 | 1.24% | |
| AEZS | Aeterna Zentaris Inc. | $17.51M | $5.72 | 2.14% | |
| TXMD | TherapeuticsMD, Inc. | $17.36M | $1.46 | 1.35% | |
| PASG | Passage Bio, Inc. | $16.97M | $0.44 | 3.41% | |
| LPCN | Lipocine Inc. | $16.93M | $3.38 | 1.05% | |
| CING | Cingulate Inc. | $16.86M | $3.92 | 1.75% | |
| LPTX | Leap Therapeutics, Inc. | $16.84M | $0.38 | 0.85% | |
| GLYC | GlycoMimetics, Inc. | $16.68M | $0.21 | 1.55% | |
| ENZ | Enzo Biochem, Inc. | $16.44M | $0.31 | 17.77% | |
| HBIO | Harvard Bioscience, Inc. | $15.87M | $0.47 | 30.32% | |
| COCP | Cocrystal Pharma, Inc. | $15.82M | $1.71 | 9.97% | |
| RLMD | Relmada Therapeutics, Inc. | $14.24M | $0.75 | 3.92% | |
| ERNA | Eterna Therapeutics Inc. | $13.71M | $0.22 | 4.80% | |
| EQ | Equillium, Inc. | $13.57M | $0.39 | 12.68% | |
| ME | 23andMe Holding Co. | $13.34M | $0.61 | 0.00% | |
| IBIO | iBio, Inc. | $12.95M | $0.77 | 1.48% | |
| UBX | Unity Biotechnology, Inc. | $12.91M | $0.70 | 2.84% | |
| RLYB | Rallybio Corporation | $12.87M | $0.31 | 3.13% | |
| PAVM | PAVmed Inc. | $12.77M | $0.60 | 3.10% | |
| SYBX | Synlogic, Inc. | $12.75M | $1.15 | 0.00% | |
| CODX | Co-Diagnostics, Inc. | $12.72M | $0.26 | 11.28% | |
| BNGO | Bionano Genomics, Inc. | $12.25M | $3.67 | 0.55% | |
| ICU | SeaStar Medical Holding Corporation | $12.20M | $1.19 | 0.83% | |
| HOTH | Hoth Therapeutics, Inc. | $11.65M | $0.83 | 4.27% | |
| ATHA | Athira Pharma, Inc. | $10.93M | $0.31 | 10.54% | |
| NERV | Minerva Neurosciences, Inc. | $10.87M | $1.54 | 2.67% | |
| PRPO | Precipio, Inc. | $10.70M | $9.44 | 5.22% | |
| TLPH | Talphera, Inc. | $10.46M | $0.49 | 0.18% | |
| CYCN | Cyclerion Therapeutics, Inc. | $9.72M | $2.81 | 1.44% | |
| INTS | Intensity Therapeutics, Inc. | $9.27M | $0.48 | 22.16% | |
| IMNN | Imunon, Inc. | $9.06M | $2.49 | 25.13% | |
| BMRA | Biomerica, Inc. | $8.90M | $3.05 | 3.48% | |
| PHIO | Phio Pharmaceuticals Corp. | $8.86M | $2.00 | 1.96% | |
| BCLI | Brainstorm Cell Therapeutics Inc. | $8.78M | $1.12 | 0.00% | |
| NEUP | Neuphoria Therapeutics Inc. | $8.43M | $6.64 | 2.58% | |
| APRE | Aprea Therapeutics, Inc. | $8.29M | $1.74 | 3.60% | |
| CARA | Cara Therapeutics, Inc. | $8.11M | $5.32 | 2.56% | |
| AYTU | Aytu BioPharma, Inc. | $8.08M | $1.78 | 2.73% | |
| TSBX | Turnstone Biologics Corp. | $8.01M | $0.33 | 1.36% | |
| OMGA | Omega Therapeutics, Inc. | $7.90M | $0.14 | 0.00% | |
| BTAI | BioXcel Therapeutics, Inc. | $7.85M | $1.18 | 4.07% | |
| CARM | Carisma Therapeutics, Inc. | $7.76M | $0.19 | 4.56% | |
| CTXR | Citius Pharmaceuticals, Inc. | $7.70M | $0.68 | 3.74% | |
| LYRA | Lyra Therapeutics, Inc. | $7.61M | $4.93 | 1.60% | |
| BFRI | Biofrontera Inc. | $6.79M | $0.56 | 7.90% | |
| AEMD | Aethlon Medical, Inc. | $6.66M | $0.37 | 0.00% | |
| ATNF | 180 Life Sciences Corp. | $6.55M | $1.02 | 0.33% | |
| AIM | AIM ImmunoTech Inc. | $6.52M | $0.09 | 19.37% | |
| ALBT | Avalon GloboCare Corp. | $6.26M | $3.68 | 0.54% | |
| SNGX | Soligenix, Inc. | $6.15M | $1.89 | 1.56% | |
| LIPO | Lipella Pharmaceuticals Inc. | $6.07M | $2.78 | 7.02% | |
| GNPX | Genprex, Inc. | $5.63M | $0.33 | 0.24% | |
| RKDA | Arcadia Biosciences, Inc. | $5.40M | $4.71 | 0.43% | |
| AEON | AEON Biopharma, Inc. | $5.35M | $0.58 | 4.38% | |
| ENSC | Ensysce Biosciences, Inc. | $5.30M | $2.22 | 1.37% | |
| APDN | Applied DNA Sciences, Inc. | $5.15M | $0.34 | 3.43% | |
| NSTG | NanoString Technologies, Inc. | $5.07M | $0.11 | 37.43% | |
| SNOA | Sonoma Pharmaceuticals, Inc. | $4.93M | $3.47 | 2.97% | |
| TCRT | Alaunos Therapeutics, Inc. | $4.74M | $2.46 | 4.65% | |
| EVOK | Evoke Pharma, Inc. | $4.69M | $3.55 | 1.71% | |
| TTNP | Titan Pharmaceuticals, Inc. | $4.36M | $4.60 | 2.22% | |
| TTOO | T2 Biosystems, Inc. | $4.35M | $0.16 | 8.49% | |
| MYMD | MyMD Pharmaceuticals, Inc. | $4.29M | $1.81 | 0.55% | |
| JAGX | Jaguar Health, Inc. | $4.26M | $4.40 | 4.76% | |
| QNRX | Quoin Pharmaceuticals, Ltd. | $4.23M | $8.53 | 5.95% | |
| AZTR | Azitra, Inc. | $4.19M | $0.27 | 1.11% | |
| ADIL | Adial Pharmaceuticals, Inc. | $4.17M | $0.69 | 0.44% | |
| OGEN | Oragenics, Inc. | $4.08M | $0.12 | 9.37% | |
| BIAF | bioAffinity Technologies, Inc. | $3.92M | $0.28 | 16.84% |